CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$4.56
+9.62%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+33.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Rotem Eran · officer: Deputy CEO and CFO | A-Award | 510,372 | $0.00 |
| Sep 8, 2026 | Abelis Bar Berta · officer: VP Legal | A-Award | 201,141 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 1Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PARALLEL ADVISORS, LLC | Reduced | 71 | Jun 3, 2026 |
| Parallel Advisors, LLC | Unchanged | 71 | Aug 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 8, 2026